Onyee Chan

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 32

Top Topics

Acute Myeloid Leukemia

Stem Cell Transplantation

Top Venues

American journal of hematology

Blood cancer discovery

This page only lists publications with an associated author ORCID identifier.

Publications

Nicole D Vincelette, Xiaoqing Yu, Andrew T Kuykendall, Jungwon Moon, Siyuan Su, Chia-Ho Cheng, Rinzine Sammut, Tiffany N Razabdouski, Hai Vu Nguyen, Erika A Eksioglu, Onyee Chan, Najla Al Ali, Parth C Patel, Dae Hyun Lee, Shima Nakanishi, Renan B Ferreira, Elizabeth Hyjek, Qianxing Mo, Suzanne Cory, Harshani R Lawrence, Ling Zhang, Daniel J Murphy, Rami S Komrokji, Daesung Lee, Scott H Kaufmann, John L Cleveland, Seongseok Yun
Trisomy 8 Defines a Distinct Subtype of Myeloproliferative Neoplasms Driven by the MYC-Alarmin Axis. Blood cancer discovery 5 (4) (2024)
Nicole D Vincelette, Xiaoqing Yu, Andrew T Kuykendall, Jungwon Moon, Siyuan Su, Chia-Ho Cheng, Rinzine Sammut, Tiffany N Razabdouski, Hai Vu Nguyen, Erika A Eksioglu, Onyee Chan, Najla Al Ali, Parth C Patel, Dae Hyun Lee, Shima Nakanishi, Renan B Ferreira, Elizabeth Hyjek, Qianxing Mo, Suzanne Cory, Harshani R Lawrence, Ling Zhang, Daniel J Murphy, Rami S Komrokji, Daesung Lee, Scott H Kaufmann, John L Cleveland, Seongseok Yun
Trisomy 8 Defines a Distinct Subtype of Myeloproliferative Neoplasms Driven by the MYC-Alarmin Axis. Blood cancer discovery 5 (4) (2024)
Onyee Chan, Najla Al Ali, Hammad Tashkandi, Austin Ellis, Somedeb Ball, Justin Grenet, Caroline Hana, Yehuda Deutsch, Ling Zhang, Mohammad Hussaini, Jinming Song, Seongseok Yun, Chetasi Talati, Andrew T Kuykendall, Eric Padron, Alison Walker, Gail J Roboz, Pinkal Desai, David A Sallman, Kendra Sweet, Rami S Komrokji, Jeffrey Lancet
Mutations highly specific for secondary AML are associated with poor outcomes in ELN favorable risk NPM1-mutated AML. Blood advances 8 (5) (2024)
Nicole D Vincelette, Xiaoqing Yu, Andrew T Kuykendall, Jungwon Moon, Siyuan Su, Chia-Ho Cheng, Rinzine Sammut, Tiffany N Razabdouski, Hai Vu Nguyen, Erika A Eksioglu, Onyee Chan, Najla Al Ali, Parth C Patel, Dae Hyun Lee, Shima Nakanishi, Renan B Ferreira, Elizabeth Hyjek, Qianxing Mo, Suzanne Cory, Harshani R Lawrence, Ling Zhang, Daniel J Murphy, Rami S Komrokji, Daesung Lee, Scott H Kaufmann, John L Cleveland, Seongseok Yun
Trisomy 8 Defines a Distinct Subtype of Myeloproliferative Neoplasms Driven by the MYC-Alarmin Axis. Blood cancer discovery 5 (4) (2024)
Nicole D Vincelette, Xiaoqing Yu, Andrew T Kuykendall, Jungwon Moon, Siyuan Su, Chia-Ho Cheng, Rinzine Sammut, Tiffany N Razabdouski, Hai Vu Nguyen, Erika A Eksioglu, Onyee Chan, Najla Al Ali, Parth C Patel, Dae Hyun Lee, Shima Nakanishi, Renan B Ferreira, Elizabeth Hyjek, Qianxing Mo, Suzanne Cory, Harshani R Lawrence, Ling Zhang, Daniel J Murphy, Rami S Komrokji, Daesung Lee, Scott H Kaufmann, John L Cleveland, Seongseok Yun
Trisomy 8 Defines a Distinct Subtype of Myeloproliferative Neoplasms Driven by the MYC-Alarmin Axis. Blood cancer discovery (2024)
Onyee Chan, Najla H Al Ali, Hammad Tashkandi, Austin Ellis, Somedeb Ball, Justin Grenet, Caroline Hana, Yehuda Deutsch, Ling Zhang, Mohammad O Hussaini, Jinming Song, Seongseok Yun, Chetasi Talati, Andrew T Kuykendall, Eric Padron, Alison R Walker, Gail J Roboz, Pinkal Desai, David A Sallman, Kendra L Sweet, Rami S Komrokji, Jeffrey E Lancet
Mutations Highly Specific for Secondary AML are Associated with Poor Outcomes in ELN Favorable Risk NPM1-mutated AML. Blood advances (2024)
Maria Julia Montoro, Laura Palomo, Claudia Haferlach, Pamela Acha, Onyee Chan, Víctor Navarro, Yasuo Kubota, Felicitas Isabel Schulz, Manja Meggendorfer, Robert Briski, Najla Al-Ali, Blanca Xicoy, Felix Lopez, Francesc Bosch, Teresa González, Lea Naomi Eder, Andrés Jerez, Yu-Hung Hung Wang, Alessia Campagna, Valeria Santini, Teresa Bernal Del Castillo, Esperanza Such, Hwei-Fang Tien, Nicolás Díaz Varela, Uwe Platzbecker, Detlef Thomas Haase, Maria Diez Campelo, Matteo Giovanni Della Porta, Guillermo Garcia-Manero, Daniel Howard Wiseman, Ulrich Germing, Jaroslaw P Maciejewski, Rami S Komrokji, Francisco Solé, Torsten Haferlach, David Valcárcel
Influence of TP53 Gene Mutations and its Allelic Status in Myelodysplastic Syndromes with Isolated 5q Deletion. Blood (2024)
Onyee Chan, Najla Al Ali, Hammad Tashkandi, Austin Ellis, Somedeb Ball, Justin Grenet, Caroline Hana, Yehuda Deutsch, Ling Zhang, Mohammad Hussaini, Jinming Song, Seongseok Yun, Chetasi Talati, Andrew T Kuykendall, Eric Padron, Alison Walker, Gail J Roboz, Pinkal Desai, David A Sallman, Kendra Sweet, Rami S Komrokji, Jeffrey Lancet
Mutations highly specific for secondary AML are associated with poor outcomes in ELN favorable risk NPM1-mutated AML. Blood advances 8 (5) (2024)
Sylvain Garciaz, Pierre-Yves Dumas, Sarah Bertoli, David A Sallman, Justine Decroocq, Amine Belhabri, Corentin Orvain, Gaspar Aspas Requena, Celestine Simand, Kamel Laribi, Martin Carré, Alberto Santagostino, Chantal Himberlin, Pierre Peterlin, Sarah Bonnet, Onyee Chan, Jeffrey E Lancet, Rami Komrokji, François Vergez, Nicolas Chapuis, Tatiana Raskovalova, Adriana Plesa, Anne-Catherine Lhoumeau, Ariane Mineur, Marie Anne Hospital, Arnaud Pigneux, Norbert Vey, Christian Recher
Outcomes of acute myeloid leukemia patients who responded to venetoclax and azacitidine and stopped treatment. American journal of hematology (2024)
Sylvain Garciaz, Pierre-Yves Dumas, Sarah Bertoli, David A Sallman, Justine Decroocq, Amine Belhabri, Corentin Orvain, Gaspar Aspas Requena, Celestine Simand, Kamel Laribi, Martin Carré, Alberto Santagostino, Chantal Himberlin, Pierre Peterlin, Sarah Bonnet, Onyee Chan, Jeffrey E Lancet, Rami Komrokji, François Vergez, Nicolas Chapuis, Tatiana Raskovalova, Adriana Plesa, Anne-Catherine Lhoumeau, Ariane Mineur, Marie Anne Hospital, Arnaud Pigneux, Norbert Vey, Christian Recher
Outcomes of acute myeloid leukemia patients who responded to venetoclax and azacitidine and stopped treatment. American journal of hematology (2024)
Nicole D Vincelette, Xiaoqing Yu, Andrew T Kuykendall, Jungwon Moon, Siyuan Su, Chia-Ho Cheng, Rinzine Sammut, Tiffany N Razabdouski, Hai Vu Nguyen, Erika A Eksioglu, Onyee Chan, Najla Al Ali, Parth C Patel, Dae Hyun Lee, Shima Nakanishi, Renan B Ferreira, Elizabeth Hyjek, Qianxing Mo, Suzanne Cory, Harshani R Lawrence, Ling Zhang, Daniel J Murphy, Rami S Komrokji, Daesung Lee, Scott H Kaufmann, John L Cleveland, Seongseok Yun
Trisomy 8 Defines a Distinct Subtype of Myeloproliferative Neoplasms Driven by the MYC-Alarmin Axis. Blood cancer discovery 5 (4) (2024)
Nicole D Vincelette, Xiaoqing Yu, Andrew T Kuykendall, Jungwon Moon, Siyuan Su, Chia-Ho Cheng, Rinzine Sammut, Tiffany N Razabdouski, Hai Vu Nguyen, Erika A Eksioglu, Onyee Chan, Najla Al Ali, Parth C Patel, Dae Hyun Lee, Shima Nakanishi, Renan B Ferreira, Elizabeth Hyjek, Qianxing Mo, Suzanne Cory, Harshani R Lawrence, Ling Zhang, Daniel J Murphy, Rami S Komrokji, Daesung Lee, Scott H Kaufmann, John L Cleveland, Seongseok Yun
Trisomy 8 Defines a Distinct Subtype of Myeloproliferative Neoplasms Driven by the MYC-Alarmin Axis. Blood cancer discovery (2024)
Parth C Patel, Somedeb Ball, Akriti Gupta Jain, Chen Wang, Mohammad O Hussaini, Luis E Aguirre, Onyee Chan, Seongseok Yun, Andrew T Kuykendall, Eric Padron, Kendra L Sweet, Jeffrey E Lancet, Rami S Komrokji, David A Sallman
Drivers of deep molecular response and long-term outcomes in patients with core binding factor acute myeloid leukemia. American journal of hematology (2023)
Farah Fleti, Onyee Chan, Amritpal Singh, Maymona G Abdelmagid, Aref A Al-Kali, Michelle A Elliott, Kebede H Begna, James M Foran, Talha Badar, Nandita Khera, Najla H Al Ali, Eric Padron, David A Sallman, Mithun Vinod Shah, Devendra K Hiwase, Animesh D Pardanani, Daniel A Arber, Attilio Orazi, Kaaren K Reichard, Rong He, Rhett P Ketterling, Naseema Gangat, Rami S Komrokji, Ayalew Tefferi
TP53 mutations and variant allele frequency in myelodysplastic syndromes with del(5q): a Mayo-Moffitt study of 156 informative cases. American journal of hematology (2023)
Farah Fleti, Onyee Chan, Amritpal Singh, Maymona G Abdelmagid, Aref A Al-Kali, Michelle A Elliott, Kebede H Begna, James M Foran, Talha Badar, Nandita Khera, Najla H Al Ali, Eric Padron, David A Sallman, Mithun Vinod Shah, Devendra K Hiwase, Animesh D Pardanani, Daniel A Arber, Attilio Orazi, Kaaren K Reichard, Rong He, Rhett P Ketterling, Naseema Gangat, Rami S Komrokji, Ayalew Tefferi
TP53 mutations and variant allele frequency in myelodysplastic syndromes with del(5q): A Mayo-Moffitt study of 156 informative cases. American journal of hematology (2023)
Rami S Komrokji, Luis E Aguirre, Najla Al-Ali, Onyee Chan, Zhuoer Xie, Andrew T Kuykendall, Kendra L Sweet, Jeffrey E Lancet, Eric Padron, David A Sallman
Activity of luspatercept and ESAs combination for treatment of anemia in lower-risk myelodysplastic syndromes. Blood advances (2023)
Luis E Aguirre, Najla Al Ali, David A Sallman, Somedeb Ball, Akriti G Jain, Onyee Chan, Sara M Tinsley-Vance, Andrew Kuykendall, Kendra Sweet, Jeffrey E Lancet, Eric Padron, Rami S Komrokji
Assessment and validation of the molecular international prognostic scoring system for myelodysplastic syndromes. Leukemia (2023)
Farah Fleti, Onyee Chan, Amritpal Singh, Maymona G Abdelmagid, Aref A Al-Kali, Michelle A Elliott, Kebede H Begna, James M Foran, Talha Badar, Nandita Khera, Najla H Al Ali, Eric Padron, David A Sallman, Mithun Vinod Shah, Devendra K Hiwase, Animesh D Pardanani, Daniel A Arber, Attilio Orazi, Kaaren K Reichard, Rong He, Rhett P Ketterling, Naseema Gangat, Rami S Komrokji, Ayalew Tefferi
TP53 mutations and variant allele frequency in myelodysplastic syndromes with del(5q): A Mayo-Moffitt study of 156 informative cases. American journal of hematology 98 (4) (2023)
Farah Fleti, Onyee Chan, Amritpal Singh, Maymona G Abdelmagid, Aref A Al-Kali, Michelle A Elliott, Kebede H Begna, James M Foran, Talha Badar, Nandita Khera, Najla H Al Ali, Eric Padron, David A Sallman, Mithun Vinod Shah, Devendra K Hiwase, Animesh D Pardanani, Daniel A Arber, Attilio Orazi, Kaaren K Reichard, Rong He, Rhett P Ketterling, Naseema Gangat, Rami S Komrokji, Ayalew Tefferi
TP53 mutations and variant allele frequency in myelodysplastic syndromes with del(5q): A Mayo-Moffitt study of 156 informative cases. American journal of hematology 98 (4) (2023)
Ellin Berman, Neil P Shah, Michael W Deininger, Jessica K Altman, Maria Amaya, Kebede H Begna, Ravi Bhatia, Onyee Chan, Robert H Collins, Peter Curtin, Daniel J DeAngelo, Michael W Drazer, Lori Maness, Leland L Metheny, Sanjay Mohan, Joseph Moore, Vivian Oehler, Keith W Pratz, Iskra Pusic, Michal Rose, William Shomali, B Douglas Smith, Michael Styler, Kendra Sweet, Moshe Talpaz, Tiffany Tanaka, Srinivas Tantravahi, Steven Tsai, Jennifer Vaughn, Jeanna Welborn, David Yang, Michael Mauro, Jorge E Cortes, Jerald Radich, Brian J Druker
CML and the WHO: Why? Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Farah Fleti, Onyee Chan, Amritpal Singh, Maymona G Abdelmagid, Aref A Al-Kali, Michelle A Elliott, Kebede H Begna, James M Foran, Talha Badar, Nandita Khera, Najla H Al Ali, Eric Padron, David A Sallman, Mithun Vinod Shah, Devendra K Hiwase, Animesh D Pardanani, Daniel A Arber, Attilio Orazi, Kaaren K Reichard, Rong He, Rhett P Ketterling, Naseema Gangat, Rami S Komrokji, Ayalew Tefferi
TP53 mutations and variant allele frequency in myelodysplastic syndromes with del(5q): A Mayo-Moffitt study of 156 informative cases. American journal of hematology 98 (4) (2023)
Rami S Komrokji, Avani M Singh, Najla Al Ali, Onyee Chan, Eric Padron, Kendra Sweet, Andrew Kuykendall, Jeffrey E Lancet, David A Sallman
Assessing the role of venetoclax in combination with hypomethylating agents in higher risk myelodysplastic syndrome. Blood cancer journal 12 (11) (2022)
Somedeb Ball, Akriti G Jain, Luis E Aguirre, Najla Al Ali, Yumeng Zhang, Onyee Chan, Andrew T Kuykendall, Kendra L Sweet, Jeffrey E Lancet, David M Swoboda, Eric Padron, Rami S Komrokji, David A Sallman
Hypomethylating agent and venetoclax in patients with chronic myelomonocytic leukemia: Is the combination indeed better? American journal of hematology 97 (5) (2022)
David M Swoboda, Rashmi Kanagal-Shamana, Andrew M Brunner, Thomas Cluzeau, Onyee Chan, Najla Al Ali, Guillermo Montalban-Bravo, Quinto J Gesiotto, Alexander Gavralidis, Anthony M Hunter, Jung-Hoon Lee, Andrew T Kuykendall, Chetasi Talati, Kendra L Sweet, Jeffrey E Lancet, Eric Padron, Mohammad Hussaini, Jinming Song, Guillermo Garcia Manero, Rami S Komrokji, David A Sallman
Marrow ring sideroblasts are highly predictive for TP53 mutation in MDS with excess blasts. Leukemia 36 (4) (2022)
Onyee Chan, Aline Renneville, Eric Padron
Chronic myelomonocytic leukemia diagnosis and management. Leukemia 35 (6) (2021)
Aline Renneville, Mirinal S Patnaik, Onyee Chan, Eric Padron, Eric Solary
Increasing recognition and emerging therapies argue for dedicated clinical trials in chronic myelomonocytic leukemia. Leukemia 35 (10) (2021)
Anthony M Hunter, Hannah Newman, Amy E Dezern, David P Steensma, Sandrine Niyongere, Gail J Roboz, Qianxing Mo, Onyee Chan, Aaron Gerds, David A Sallman, William Dominguez-Viqueira, Christopher Letson, Maria E Balasis, Markus Ball, Traci Kruer, Hailing Zhang, Jeffrey E Lancet, Alan F List, Mikkael A Sekeres, Rami S Komrokji, Eric Padron
Integrated Human and Murine Clinical Study Establishes Clinical Efficacy of Ruxolitinib in Chronic Myelomonocytic Leukemia. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (22) (2021)
Onyee Chan, Rami S Komrokji
Luspatercept in the treatment of lower-risk myelodysplastic syndromes. Future oncology (London, England) 17 (12) (2021)
Rami S Komrokji, Virginia Volpe, Onyee Chan, Najla Al Ali, David Swoboda, Andrew Kuykendall, Eric Padron, David M Swoboda
Validation of the international working group proposal for SF3B1 mutant myelodysplastic syndromes. Blood 138 (11) (2021)
David M Swoboda, Najla Al Ali, Onyee Chan, Eric Padron, Andrew T Kuykendall, Jinming Song, Mohammad Hussaini, Chetasi Talati, Kendra Sweet, Jeffrey E Lancet, David A Sallman, Rami S Komrokji
PTPN11 mutations are associated with poor outcomes across myeloid malignancies. Leukemia 35 (1) (2020)
Alexandra Sokolova, Onyee Chan, Waqas Ullah, Auon Abbas Hamdani, Faiz Anwer
Delayed rhabdomyolysis with paclitaxel, ifosfamide, carboplatin, and etoposide regimen: a case report. Journal of medical case reports 11 (1) (2017)
Onyee Chan, Abdur Rehman Jamil, Rebecca Millius, Ramandeep Kaur, Faiz Anwer
Mixed phenotype acute leukemia with t(9;22): success with nonacute myeloid leukemia-type intensive induction therapy and stem cell transplantation. Clinical case reports 5 (4) (2017)